Delcath Systems (DCTH)
Delcath Systems Market Cap: 72.75M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
DCTH Market Cap Rankings
| Overall | 19th percentile | 3741 of 4649 |
| Sector | 24th percentile | 394 of 525 in Healthcare |
| Industry | 30th percentile | 9 of 13 in Drug Delivery & Accessories |
DCTH Market Cap Range, Past 5 Years
| Minimum | 30.14M | Dec 2008 |
| Maximum | 429.33M | Dec 2010 |
| Average | 152.61M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these DCTH related companies
DCTH News
Notable 52-Week Highs and Lows of the Day 05/25: (LCC) (RPRX) High; (DCTH) (MXWL) (VIP) Low
May 25, 3:09PM Street Insider
May 25, 3:09PM Street Insider
Unusual 11 Mid-Day Movers 05/25: (GNOM) (UPI) (RPRX) Higher; (TLB) (DCTH) (PAY) Lower
May 25, 1:42PM Street Insider
May 25, 1:42PM Street Insider
Morning Movers 05/25: (GNOM) (UPI) (EJ) Higher; (DCTH) (TLB) (GENE) Lower
May 25, 10:39AM Street Insider
May 25, 10:39AM Street Insider
Pre-Open Movers 5/25: (BLOX) (FRO) (QSFT) Higher; (TLB) (ROSG) (DCTH) Lower (more...)
May 25, 9:33AM Street Insider
May 25, 9:33AM Street Insider
Delcath (DCT) Prices 13.3M Shares at $1.50/Share, Sees Net Proceeds of $18.4M
May 25, 8:54AM Street Insider
May 25, 8:54AM Street Insider
$peix small posistion from .56 gnna let it run. Hoping for 1 will see if it gets there. Looking to add $lvs $dcth on drop
about 3 days ago by trapp303
about 3 days ago by trapp303
Listen to $DCTH Delcath Systems 2012 Annual Shareholder Meeting - live at 10:00 AM, ondemand after - http://stks.co/3x8u
about 5 days ago by earningscast
about 5 days ago by earningscast
Listen to $DCTH Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3jHZ
about 20 days ago by earningscast
about 20 days ago by earningscast
$DCTH forms bearish "Flag" chart pattern. http://stks.co/3fO8
about 25 days ago by RecogniaEvents
about 25 days ago by RecogniaEvents
$DCTH forms bullish "Continuation Wedge" chart pattern. http://stks.co/3cFs
about 27 days ago by RecogniaEvents
about 27 days ago by RecogniaEvents
Delcath To Report Fiscal 2012 First Quarter Results And Conduct Conference Call
May 01, 6:30AM PR Newswire
May 01, 6:30AM PR Newswire
Low Side Effects Seen in Treatment With Delcath's Second Generation Hemofiltration Cartridge
Apr 26, 7:38AM PR Newswire
Apr 26, 7:38AM PR Newswire
$DCTH Filled gap down to $2.60. Bounced off of 76% Fib. Green day tomorrow confirms buy.
about 35 days ago by ballhawker
about 35 days ago by ballhawker
RT @wsmco Silicon Valley Bank arranges $20 mil revolving credit with $DCTH http://stks.co/3TJh EXCELLENT BULLISH NEWS!
about 35 days ago by ballhawker
about 35 days ago by ballhawker
Silicon Valley Bank arranges $20 mil revolving credit with $DCTH http://stks.co/3SP4
about 35 days ago by wsmco
about 35 days ago by wsmco
Delcath - 1st Patient Treatment Using 2nd Generation Hemofiltration Cartridge http://stks.co/3L2Q $DCTH
about 45 days ago by evcgroup
about 45 days ago by evcgroup
Delcath Systems (DCTH) Reports First CHEMOSAT Treatment with Hemofiltration Cartridge
Apr 13, 6:32AM Street Insider
Apr 13, 6:32AM Street Insider
Delcath Announces First Patient Treatment Using Second Generation Hemofiltration Cartridge
Apr 13, 6:30AM PR Newswire
Apr 13, 6:30AM PR Newswire
$DCTH OMG...good news AND a rise in the stock price. I think I might faint
about 46 days ago by venturablvd
about 46 days ago by venturablvd
Delcath Agreement W/ Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital for Training/Launch of Chemosat http://stks.co/3Hq1 $DCTH
about 48 days ago by evcgroup
about 48 days ago by evcgroup
Reuters: Delcath Systems Receives European Regulatory Approval For 2nd Generation Hemofiltration Cartridge http://stks.co/3Fat $DCTH
about 52 days ago by evcgroup
about 52 days ago by evcgroup
Delcath Receives European Regulatory Approval for 2nd Gen Hemofiltration Cartridge http://stks.co/3EgK $DCTH
about 53 days ago by evcgroup
about 53 days ago by evcgroup
$DCTH reports they have received European approval for their second generation cartridge for their CHEMOSAT system http://stks.co/3EVI
about 53 days ago by wsmco
about 53 days ago by wsmco
Delcath Receives European Regulatory Approval for Second Generation Hemofiltration Cartridge
Apr 05, 6:39AM Benzinga
Apr 05, 6:39AM Benzinga
Delcath Announces Agreement W/ Istituto Nazionale Tumori Fondazione G. Pascale for Further Expansion in Italy http://stks.co/35sv $DCTh
about 62 days ago by evcgroup
about 62 days ago by evcgroup
Delcath (DCTH) Enters CHEMOSAT Launch Agreement with INT in Naples, Italy
Mar 27, 6:34AM Street Insider
Mar 27, 6:34AM Street Insider
Delcath Expands Global Marketing Team With Key Pharma Oncology Hire http://stks.co/34Xp $DCTH
about 63 days ago by evcgroup
about 63 days ago by evcgroup
Delcath Announces Agreement with Instituto Oncologico Baselga for Launch of CHEMOSAT in Spain
Mar 19, 6:40AM Benzinga
Mar 19, 6:40AM Benzinga
Delcath Systems (DCTH) Enters Lauch, Training Agreement for Hepatic CHEMOSAT
Mar 19, 6:31AM Street Insider
Mar 19, 6:31AM Street Insider
Delcath Systems (DCTH) Enters Launch, Training Agreement for CHEMOSAT with IGR
Mar 15, 6:34AM Street Insider
Mar 15, 6:34AM Street Insider
Quintiles to Provide Specialized MSUs for Delcath (DCTH) CHEMOSAT Launch
Mar 09, 6:32AM Street Insider
Mar 09, 6:32AM Street Insider
Delcath Highlights Fiscal 2011 Fourth Quarter and Full Year Results and Recent Developments
Mar 08, 5:47PM PR Newswire
Mar 08, 5:47PM PR Newswire
Delcath to Conduct Conference Call to Discuss Full Year 2011 Results and Recent Corporate Progress
Mar 02, 6:30AM PR Newswire
Mar 02, 6:30AM PR Newswire
Delcath to Present at 24th Annual Roth Growth Stock Conference on March 12
Feb 28, 6:30AM PR Newswire
Feb 28, 6:30AM PR Newswire
Delcath (DCTH) Treats First Patients in Germany with CHEMISAT Delivery System
Feb 27, 6:33AM Street Insider
Feb 27, 6:33AM Street Insider
Delcath CHEMOSAT Presented as Innovative Treatment for Liver Metastases by European Institute of Oncology
Feb 15, 2:52PM PR Newswire
Feb 15, 2:52PM PR Newswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| DCTH | 1.50 | -0.88 | -36.97% | 72.75M |
| DCT | 5.81 | -0.04 | -0.68% | 1.436B |
| DCOM | 13.34 | +0.04 | +0.30% | 469.17M |
| DAKT | 7.15 | -0.03 | -0.42% | 299.23M |
| DAIO | 2.66 | +0.06 | +2.30% | 24.50M |
| DAC | 4.06 | +0.06 | +1.50% | 442.58M |
| D | 52.55 | +0.05 | +0.10% | 29.99B |
| CZZ | 11.90 | +0.13 | +1.10% | 2.075B |
| CZWI | 6.15 | +0.10 | +1.65% | 31.43M |
| CZR | 12.50 | -0.22 | -1.73% |